Back to results
US 2021/0070871 A1Published application
Optimized anti-tl1a antibodies
AssigneePrometheus Biosciences, Inc.
InventorsJeffry D. WATKINS, Cindy T. DICKERSON, J. Monty WATKINS, Patricia MCNEELEY
Life of this patent
Estimating the term…
Abstract
Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohns Disease (CD) and ulcerative colitis (UC).
Claims48
An antibody or antigen-binding fragment that specifically binds TL1A, comprising:
- a heavy chain variable region comprising:
- (a) an HCDR1 comprising an amino acid sequence set forth by SEQ ID NO:
- 553;
- (b) an HCDR2 comprising an amino acid sequence set forth by any one of SEQ ID NOs:
- 554 to 564 or 574 to 577;
- and
- (c) an HCDR3 comprising an amino acid sequence set forth by any one of SEQ ID NOs:
- 565 to 568 or 578 to 581;
- and
- a light chain variable region comprising:
- (d) an LCDR1 comprising an amino acid sequence set forth by any one of SEQ ID NOs:
- 569 or 570;
- (e) an LCDR2 comprising an amino acid sequence set forth by SEQ ID NO:
- 488;
- and
- (f) an LCDR3 comprising an amino acid sequence set forth by any one of SEQ ID NOs:
- 571 to 573 or 582 to 585.
14 more elements
An antibody or antigen-binding fragment that specifically binds TL1A, comprising:
- a heavy chain variable region comprising:
- (a) an HCDR1, an HCDR2, and an HCDR3 selected from any one of SEQ ID NOs:
- 491, 493, 495, 497, 499, 501, 503, 505, 507, 509, 511, 513, 515, 517, 519, 521, 523, 525, 527, 529, 531, 533, 535, 537, 539, or 541;
- and
- a light chain variable region comprising
- (b) an LCDR1, an LCDR2, and an LCDR3 selected from any one of SEQ ID NOs:
- 490, 492, 494, 496, 498, 500, 502, 504, 506, 508, 510, 512, 514, 516, 518, 520, 522, 524, 526, 528, 530, 532, 534, 536, 538, or 540;
- wherein the CDRs are defined by the Kabat, Chothia, or IMGT method or a combination thereof.
5 more elements
An antibody or antigen-binding fragment that specifically binds TL1A, comprising:
- (a) a heavy chain variable region comprising an amino acid sequence at least about 90% identical to any one of SEQ ID NOs:
- 491, 493, 495, 497, 499, 501, 503, 505, 507, 509, 511, 513, 515, 517, 519, 521, 523, 525, 527, 529, 531, 533, 535, 537, 539, or 541;
- and
- (b) a light chain variable region comprising an amino acid sequence at least about 90% identical to any one of SEQ ID NOs:
- 490, 492, 494, 496, 498, 500, 502, 504, 506, 508, 510, 512, 514, 516, 518, 520, 522, 524, 526, 528, 530, 532, 534, 536, 538, or 540.
2 more elements
Dependencies are inferred from the claim text.